Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2002 Aug;93(8):867–873. doi: 10.1111/j.1349-7006.2002.tb01331.x

Estradiol Stabilizes p53 Protein in Breast Cancer Cell Line, MCF–7

Naoki Okumura 1,✉, Shigehira Saji 1,4, Hidetaka Eguchi 3,5, Shin‐ichi Hayashi 3, Shigetoyo Saji 3, Shigeru Nakashima 2
PMCID: PMC5927107  PMID: 12716463

Abstract

Overexpression of the oncoprotein MDM2, an important regulator of the p53 tumor suppressor protein, is often observed in breast cancer tissues and cell lines, particularly in those which express estrogen receptor a (ERa). In MCF–7 breast cancer cell line possessing wild‐type p53, ERa, and overexpressing MDM2, p53 accumulation was stimulated by 17β‐estradiol (E2) in a concentrationdependent manner. On the other hand, E2 caused no change of the expression of p53 mRNA, indicating that E2 affects p53 at the post‐transcriptional level. To analyze the mechanism of p53 accumulation by E2, the stability of p53, ERa and MDM2 proteins was analyzed in the presence of cycloheximide under an E2–supplemented or‐depleted condition. E2 significantly extended the half‐life of p53 protein, but shortened that of ERa in MCF–7 cells. E2 significantly decreased the stability of p90(MDM2) and p60(MDM2) in MCF–7. Interestingly, E2 increased the ratio p60(MDM2)/p90(MDM2) inversely proportionally to the degradation of p53. These results suggest that the ratio of the two MDM2 proteins, p90(MDM2) and p60(MDM2), may affect the accumulation of wild‐type p53 protein in response to E2.

Keywords: Breast cancer, p53, MDM2, Estrogen receptor

Full Text

The Full Text of this article is available as a PDF (543.3 KB).

REFERENCES

  • 1. ) Oliner , J. D. , Kinzler , K. W. , Melzer , P. S. , George , D. L. and Vogelstein , B.Amplification of a gene encoding a p53–associated protein in human sarcomas . Nature , 358 , 80 – 83 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Cordon‐Cardo , C. , Latres , E. , Drobnjak , M. , Oliva , M. R. , Pollack , D. , Woodruff , J. M. , Marechal , V. J. , Chen , J. , Brennan , M. F. and Levine , A. J.Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas . Cancer Res. , 54 , 794 – 799 ( 1994. ). [PubMed] [Google Scholar]
  • 3. ) Quesnel , B. , Preudhomme , C. , Fouriner , J. , Fenaux , P. and Peyrat , J. P.MDM2 gene amplification in human breast cancer . Eur. J. Cancer , 30A , 982 – 984 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) McCann , A. H. , Kirley , A. , Carney , D. N. , Corbally , N. , Magee , H. M. , Keating , G. and Dervan , P. A.Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status . Br. J. Cancer , 71 , 981 – 985 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. ) Fakharzadeh , S. S. , Trusko , S. P. and George , D. L.Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line . EMBO J. , 10 , 1565 – 1569 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Momand , J. , Zambetti , G. P. , Olson , D. C. , George , D. and Levine , A. J.The mdm–2 oncogene product forms a complex with the p53 protein and inhibits p53–mediated transactivation . Cell , 69 , 1237 – 1245 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Boddy , M. N. , Freemont , P. S. and Borden , K. L.The p53–associated protein MDM2 contains a newly characterized zinc‐binding domain called the RING finger . Trends Biochem. Sci. , 19 , 198 – 199 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Kussie , P. H. , Gorina , S. , Marechal , V. , Elenbaas , B. , Moreau , J. , Levine , A. J. and Pavletich , N. P.Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain . Science , 274 , 948 – 953 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Haupt , Y. , Maya , R. , Karaz , A. and Oren , M.Mdm2 promotes the rapid degradation of p53 . Nature , 387 , 296 – 299 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Honda , R. , Tanaka , H. and Yasuda , H.Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 . FEBS Lett. , 420 , 25 – 27 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Gudas , J. M. , Nguyen , H. , Kiein , R. C. , Katayose , D. , Seth , P. and Cowan , K. H.Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells . Clin. Cancer Res. , 1 , 71 – 80 ( 1995. ). [PubMed] [Google Scholar]
  • 12. ) Gorgoulis , V. G. , Zoumpourlis , V. , Rassidakis , G. Z. , Karameris , A. , Rassidakis , A. N. , Spandidos , D. A. and Kittas , C.A molecular and immunohistochemical study of the MDM2 protein isoforms and p53 gene product in bron‐chogenic carcinoma . J. Pathol. , 180 , 129 – 137 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Landers , J. E. , Cassel , S. L. and George , D. L.Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild‐type p53 protein . Cancer Res. , 57 , 3562 – 3568 ( 1997. ). [PubMed] [Google Scholar]
  • 14. ) Perry , M. E. , Mendrysa , S. M. , Saucedo , L. J. , Tannous , P. and Holubar , M.p76(MDM2) inhibits the ability of p90(MDM2) to destabilize p53 . J. Biol. Chem. , 275 , 5733 – 5738 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Saji , S. , Nakashima , S. , Hayashi , S. , Toi , M. , Saji , S. and Nozawa , Y.Overexpression of MDM2 in MCF–7 promotes both growth advantage and p53 accumulation in response to estradiol . Jpn. J. Cancer Res. , 90 , 210 – 218 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. ) Inada , K. , Toi , M. , Yamamoto , Y. , Suzuki , A. , Kurisaki , T. , Suzuki , H. and Tominaga , T.Immunocytochemical analysis of MDM2 protein expression and its relevance to tumor angiogenesis in primary breast cancer . Oncol. Rep. , 3 , 667 – 671 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Baunoch , D. A. , Watkins , L. F. , Tewari , A. , Reece , M. T. , Adams , L. , Stack , R. , Brown , A. , Jones , L. , Christian , D. , Latif , N. A. , Lawrence , W. D. and Lane , M. A.MDM2 overexpression in benign and malignant lesions of the human breast, association with ERα expression . Int. J. Oncol. , 8 , 895 – 899 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Hideshima , T. , Baba , M. and Shirakusa , T.The expression of MDM2 and p53 protein in breast carcinoma . Oncol. Rep. , 4 , 297 – 300 ( 1997. ). [PubMed] [Google Scholar]
  • 19. ) Marchetti , A. , Buttitta , F. , Girlando , S. , Dalla Palma , P. , Pellegrini , S. , Fina , P. , Doglioni , C. , Bevilacqua , G. and Barbareschi , M.mdm2 gene alterations and mdm2 protein expression in breast carcinomas . J. Pathol. , 175 , 31 – 38 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Seshadri , R. , Leong , A. S. , McCaul , K. , Firgaira , F. A. , Setlur , V. and Horsfall , D. J.Relationship between p53 gene abnormalities and other tumour characteristics in breast‐cancer prognosis . Int. J. Cancer , 69 , 135 – 141 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Gretarsdottir , S. , Tryggvadottir , L. , Jonasson , J. G. , Sigurdsson , H. , Olafsdottir , K. , Agnarsson , B. A. , Ogmundsdottir , H. and Eyfjord , J. E.TP53 mutation analyses on breast carcinomas, a study of paraffin‐embedded archival material . Br. J. Cancer , 74 , 555 – 561 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. ) Liu , G. , Schwartz , J. A. and Brooks , S. C.p53 down‐regulates ER‐responsive genes by interfering with the binding of ER to ERE . Biochem. Biophys. Res. Commun. , 264 , 359 – 364 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Molinari , A. M. , Bontempo , P. , Schiavone , E. M. , Tortora , V. , Verdicchio , M. A. , Napolitano , M. , Nola , E. , Moncharmont , B. , Medici , N. , Nigro , V. , Armetta , I. , Abbondanza , C. and Puca , G. A.Estradiol induces functional inactivation of p53 by intracellular redistribution . Cancer Res. , 60 , 2594 – 2597 ( 2000. ). [PubMed] [Google Scholar]
  • 24. ) Saji , S. , Okumura , N. , Eguchi , H. , Nakashima , S. , Suzuki , A. , Toi , M. , Nozawa , Y. , Saji , S. and Hayashi , S.MDM2 enhances the function of estrogen receptor a in human breast cancer cells . Biochem. Biophys. Res. Commun. , 281 , 259 – 265 ( 2001. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Okumura , N. , Saji , S. , Eguchi , H. , Nakashima , S. , Saji , S. and Hayashi , S.Distinct promoter usage of mdm2 gene in human breast cancer . Oncol. Rep. , 9 , 557 – 563 ( 2002. ). [PubMed] [Google Scholar]
  • 26. ) Runnebaum , I. B. , Nagarajan , M. , Bowman , M. , Soto , D. and Sukumar , S.Mutations in p53 as potential molecular markers for human breast cancer . Proc. Natl. Acad. Sci. USA , 88 , 10657 – 10661 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. ) Pemg , Y. , Chen , L. , Li , C. , Lu , W. , Agrawal , S. and Chen , J.Stabilization of the MDM2 oncoprotein by mutant p53 . J. Biol. Chem. , 276 , 6874 – 6878 ( 2001. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Zakut‐Houri , R. , Bienz‐Tadmor , B. , Givol , D. and Oren , M.Human p53 cellular tumor antigen, cDNA sequence and expression in COS cells . EMBO J. , 4 , 1251 – 1255 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. ) Giaccia , A. J. and Kastan , M. B.The complexity of p53 modulation, emerging patterns from divergent signals . Genes Dev. , 12 , 2973 – 2983 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Delmolino , L. , Band , H. and Band , V.Expression and stability of p53 protein in normal human mammary epithelial cells . Carcinogenesis , 14 , 827 – 832 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Sigal , A. and Rotter , V.Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome . Cancer Res. , 60 , 6788 – 6793 ( 2000. ). [PubMed] [Google Scholar]
  • 32. ) Pink , J. J. and Jordan , V. C.Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines . Cancer Res. , 56 , 2321 – 2330 ( 1996. ). [PubMed] [Google Scholar]
  • 33. ) Buschmann , T. , Fuchs , S. Y. , Lee , C. G. , Pan , Z. Q. and Ronai , Z.SUMO–1 modification of Mdm2 prevents its self‐ubiquitination and increases Mdm2 ability to ubiquitinate p53 . Cell , 101 , 753 – 762 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 34. ) Chen , L. , Marechal , V. , Moreau , J. , Levine , A. J. and Chen , J.Proteolytic cleavage of the mdm2 oncoprotein during apoptosis . J. Biol. Chem. , 272 , 22966 – 22973 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 35. ) Pochampally , R. , Fodera , B. , Chen , L. , Lu , W. and Chen , J.Activation of an MDM2–specific caspase by p53 in the absence of apoptosis . J. Biol. Chem. , 274 , 15271 – 15277 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Peng , Y. , Chen , L. , Li , C. , Lu , W. and Chen , J.Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization . J. Biol. Chem. , 276 , 40583 – 40590 ( 2001. ). [DOI] [PubMed] [Google Scholar]
  • 37. ) Asher , G. , Lotem , J. , Kama , R. , Sachs , L. and Shaul , Y.NQO1 stabilizes p53 through a distinct pathway . Proc. Natl. Acad. Sci. USA , 99 , 3099 – 3104 ( 2002. ). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES